Dont underestimate the many strings to Primas bow.
It should be remembered that Primas technology will apply to a multitude of different cancers, significantly enhancing its appeal to both investors and potential takeover suitors.
Added to that is the oral delivery system for gardasil, which I believe, is not factored in or valued highly enough by some analysts and investors. IMO, this will add SIGNIFICANTLY to Primas revenue stream, and put it way ahead of the pack amongst its peers.
Like I have said for years...the calibre of personel involved with Prima Biomed would simply not be there risking reward and reputation if there was not a very very strong chance of success!
Dont underestimate the many strings to Primas bow.It should be...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.008(2.38%) |
Mkt cap ! $465.4M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.3¢ | 31.0¢ | $594.7K | 1.866M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 105941 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 477970 | 33 |
View Market Depth
| Last trade - 15.51pm 10/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |